Feasibility for commercialization of AI-driven prosthetic design software to improve global access to prosthetic care

The Nederlandse Organisatie voor Wetenschappelijk Onderzoek, specifically through Toegepaste en Technische Wetenschappen, has issued an award notice for a Phase-1 Take-off study titled Feasibility for commercialization of AI-driven prosthetic design software to improve global access to prosthetic care. This initiative focuses on MORPHA, an AI-driven software solution designed to automate the creation of above- and below-knee prosthetic sockets. By reducing design time to roughly two minutes and decreasing the dependency on highly specialized staff, the technology aims to lower healthcare costs and expand access to well-fitting prostheses in both high-income and low-to-middle-income countries. The primary objective of this contract is to evaluate the commercial potential, market opportunities, and overall implementation strategy for the MORPHA system. By assessing the feasibility of commercialization, the project seeks to address the global challenge of limb loss and the current limitations in prosthetic care availability. The award, identified by solicitation number 23530, represents a strategic effort to make prosthetic care more efficient, affordable, and accessible on a global scale.